Recombinant Tropheryma whipplei GMP synthase [glutamine-hydrolyzing] (guaA), partial

Shipped with Ice Packs
In Stock

Description

Introduction

GMP synthetase (EC 6.3.4.1), encoded by the guaA gene in Tropheryma whipplei, is a glutamine amidotransferase (GAT) critical for guanosine monophosphate (GMP) biosynthesis. This enzyme catalyzes the amination of xanthosine monophosphate (XMP) to GMP using glutamine and ATP, with ammonia channeling between its two catalytic domains. Recombinant forms of this enzyme, including partial constructs, are studied for structural, functional, and therapeutic applications, particularly in understanding T. whipplei’s pathogenicity and metabolic vulnerabilities .

Biochemical Characteristics

Catalytic Mechanism:
T. whipplei GMP synthetase operates through two sequential reactions:

  1. Glutaminolysis: Hydrolysis of glutamine to glutamate and ammonia in the glutaminase (GATase) domain.

  2. Amination: Transfer of ammonia to the adenyl-XMP intermediate (formed via ATP hydrolysis) in the ATP pyrophosphatase (ATPPase) domain .

Key Features:

  • Domain Architecture: A single polypeptide with distinct GATase (Cys-His-Glu catalytic triad) and ATPPase (ATP-binding) domains .

  • Allosteric Regulation: ATP and XMP binding to the ATPPase domain activate the GATase domain, enhancing glutamine hydrolysis .

  • Ammonia Channeling: A spatially separated but functionally linked pathway ensures efficient transfer of ammonia between domains .

Functional Role in Tropheryma whipplei

Metabolic Importance:
GMP synthetase is essential for T. whipplei’s nucleotide biosynthesis, supporting DNA replication, transcription, and energy metabolism. Its activity is tightly regulated by ATPPase domain occupancy, ensuring metabolic efficiency .

Pathogenic Relevance:

  • Drug Target Potential: As an intracellular pathogen with a reduced genome, T. whipplei relies heavily on GMP synthetase for survival, making it a candidate for antimicrobial intervention .

  • Genetic Resistance: While T. whipplei exhibits fluoroquinolone resistance via mutations in gyrA/parC, GMP synthetase remains a viable therapeutic target .

Recombinant Production and Applications

Recombinant Constructs:
Partial recombinant GMP synthase fragments are often used to study:

  1. Domain-Specific Interactions: Isolated GATase or ATPPase domains for mechanistic studies .

  2. Catalytic Efficiency: Kinetic parameters (e.g., K<sub>m</sub>, V<sub>max</sub>) under varying substrate conditions .

  3. Crystallization: Structural elucidation of domain interactions or ligand-binding motifs .

Experimental Models:

  • Heterologous Expression: Typically in E. coli or insect cells, using the guaA gene from T. whipplei Twist or other strains .

  • Functional Assays: Enzyme activity measured via GMP production, glutamate release, or ATP hydrolysis .

Data Tables

Table 1: Key Functional Studies

Study FocusFindingsSource
Allosteric ActivationATP·XMP binding enhances GATase activity
Ammonia ChannelingConfirmed via ¹⁵N NMR in Plasmodium GMPS
Interdomain CommunicationGATase inactive without ATPPase ligands

Table 2: Genomic Context of guaA

FeatureDescriptionSource
Operon StructurePolycistronic guaBA operon
Termination SignalRho-independent (dyad symmetry)
mRNA 3ʹ End36–37 nt downstream of stop codon

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
guaA; TWT_079; GMP synthase [glutamine-hydrolyzing]; EC 6.3.5.2; GMP synthetase; Glutamine amidotransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Tropheryma whipplei (strain Twist) (Whipple's bacillus)
Target Names
guaA
Uniprot No.

Target Background

Function

Catalyzes the synthesis of GMP from XMP.

Database Links

KEGG: twh:TWT_079

STRING: 203267.TWT079

Q&A

What is Tropheryma whipplei and why is its GMP synthase significant for research?

Tropheryma whipplei is the causative agent of Whipple's disease, a rare systemic infectious disease affecting multiple organ systems. T. whipplei belongs to the high-G+C-content gram-positive bacterial group between the genus Cellulomonas and the actinomycete clade . This bacterium is particularly notable as the only known reduced genome species (<1 Mb) within the Actinobacteria .

GMP synthase (guaA) is significant because:

  • It catalyzes the ATP-dependent amidation of XMP to GMP using glutamine as an amide donor

  • Glutamine is predicted to be essential for nucleotide synthesis in T. whipplei

  • Due to metabolic deficiencies in T. whipplei, this enzyme represents a potential vulnerability that could be exploited for therapeutic purposes

What genomic characteristics make T. whipplei challenging to study?

T. whipplei presents several genomic challenges that impact research approaches:

Genomic FeatureCharacteristicResearch Implication
Genome size0.92 Mb Reduced metabolic capacity requiring specialized growth conditions
CultivationHistorically difficult to cultureOnly successfully isolated in eukaryotic cells and propagated in culture in 2000
Metabolic deficiencyMissing pathways for amino acid biosynthesisRequires supplementation with essential nutrients
DNA compositionHigh G+C contentMay create challenges for DNA manipulation and expression in common host systems
Gene regulationLimited complement of information processing genesPotentially unique regulatory mechanisms controlling enzyme expression

Methodological approach: When working with T. whipplei genes, researchers should account for these genomic constraints by optimizing codon usage for expression hosts, providing essential metabolites in culture conditions, and verifying gene sequence identity against the reference genome.

What expression systems are recommended for recombinant T. whipplei proteins?

The optimal expression of recombinant T. whipplei proteins, including GMP synthase, requires careful consideration of expression systems:

Bacterial expression systems are recommended for routine production of smaller recombinant proteins that do not require post-translational modifications . For T. whipplei GMP synthase:

Expression System ComponentRecommendationRationale
Host strainE. coli BL21(DE3) or Rosetta strainsRosetta strains provide additional tRNAs for rare codons present in high G+C organisms
Expression vectorpET system with T7 promoterStrong, inducible expression
Induction conditionsLow temperature (16-20°C), reduced IPTG concentrationPromotes proper folding and solubility
Fusion tagsHis6, MBP, or GSTFacilitates purification and may enhance solubility
Media supplementsGlutamine (1%)Provides essential substrate for proper folding

Methodological approach: Optimize expression by testing multiple combinations of these parameters, monitoring protein production via SDS-PAGE, and assessing solubility through small-scale purification trials before scaling up production.

How can enzymatic activity of recombinant T. whipplei GMP synthase be reliably measured?

Measuring GMP synthase activity requires specialized assays that account for the enzyme's dual-domain architecture and complex reaction mechanism:

Assay TypePrincipleAdvantagesLimitations
SpectrophotometricMeasures change in absorbance at 290 nm as XMP is converted to GMPDirect, continuous monitoringLower sensitivity, potential interference
Coupled enzymeLinks GMP production to NAD(P)H oxidation via auxiliary enzymesHigher sensitivity, continuousDependent on coupling enzyme performance
HPLC-basedDirect quantification of substrate consumption and product formationMost accurate for kinetic parametersTime-consuming, requires specialized equipment
RadioactiveUses 14C/3H-labeled glutamine to track amide transferHighest sensitivityRequires radioisotope handling facilities

Methodological protocol:

  • Prepare reaction buffer (50 mM HEPES pH 8.0, 100 mM KCl, 10 mM MgCl2, 1 mM DTT)

  • Add enzyme (0.1-1 μM purified protein)

  • Initiate reaction with substrates (1 mM ATP, 0.5 mM XMP, 5 mM glutamine)

  • Monitor reaction progress using chosen detection method

  • Include appropriate controls (without enzyme, without individual substrates)

  • Analyze data using initial rate conditions to determine kinetic parameters

How does T. whipplei GMP synthase function relate to the organism's thermal stress response?

T. whipplei exhibits unique transcription profiles in response to thermal stresses, with its transcriptome strongly modified following cold shock at 4°C . For GMP synthase activity in relation to thermal stress:

Temperature ConditionT. whipplei ResponseExperimental Approach
Heat shock (43°C)Limited transcriptome changes, up-regulation of dnaK regulon Measure GMP synthase activity at elevated temperatures; compare with enzyme stability profiles
Cold shock (4°C)149 genes differentially transcribed, increased nutrient uptake Assess enzyme kinetics at low temperatures; examine cold adaptation mechanisms
Standard growth (37°C)Baseline expression patternsEstablish reference activity measurements

Methodological approach:

  • Express and purify recombinant GMP synthase under standardized conditions

  • Subject purified enzyme to various temperature pre-treatments (4°C, 37°C, 43°C)

  • Measure enzyme activity across temperature range (4-50°C)

  • Conduct thermal shift assays to determine structural stability under different conditions

  • Correlate findings with transcriptomic data on guaA expression under thermal stress

  • Compare results with GMP synthases from related bacteria to identify T. whipplei-specific adaptations

What structural features of T. whipplei GMP synthase might explain its adaptation to a host-dependent lifestyle?

T. whipplei GMP synthase likely exhibits structural adaptations reflecting the organism's parasitic lifestyle and reduced metabolic capacity:

Structural FeaturePredicted AdaptationExperimental Investigation Method
Substrate binding pocketPotentially higher affinity for glutamineSite-directed mutagenesis of binding site residues; comparative kinetic analysis
Domain organizationOptimized interdomain communicationLimited proteolysis; SAXS analysis; domain interaction studies
Stability elementsEnhanced stability at physiological temperatureThermal denaturation studies; molecular dynamics simulations
Surface propertiesAdaptations for host environment pH/ionic conditionsActivity profiling across pH/salt conditions; electrostatic surface mapping

Methodological approach:

  • Perform homology modeling based on related bacterial GMP synthases

  • Express and purify recombinant enzyme for structural studies

  • Determine crystal structure through X-ray crystallography

  • Conduct molecular dynamics simulations under conditions mimicking host environment

  • Compare structural features with GMP synthases from free-living bacteria

  • Correlate structural insights with kinetic properties and thermal adaptation profiles

How can solubility and stability of recombinant T. whipplei GMP synthase be optimized?

Optimizing solubility and stability of recombinant T. whipplei GMP synthase requires systematic approach:

ChallengeOptimization StrategyImplementation
Low solubilityFusion partnersTest MBP, SUMO, thioredoxin tags at N-terminus
Protein aggregationBuffer optimizationScreen additives: glycerol (10-20%), arginine (50-200 mM), low concentrations of non-ionic detergents
Improper foldingExpression temperatureTest induction at 18°C, 25°C, and 30°C
Limited shelf-lifeStorage conditionsEvaluate protein stability in different buffers with cryoprotectants
Oxidation sensitivityReducing agentsInclude DTT or TCEP in all buffers; consider working under anaerobic conditions

Methodological approach:

  • Design expression constructs with different solubility-enhancing tags

  • Perform small-scale expression trials varying temperature, induction time, and media composition

  • Implement high-throughput buffer screening using thermal shift assays

  • Assess long-term stability under various storage conditions (4°C, -20°C, -80°C)

  • Validate activity retention throughout optimization process

  • Consider glutamine addition to purification buffers given its importance for T. whipplei metabolism

What are the optimal conditions for purifying active recombinant T. whipplei GMP synthase?

Purification of active T. whipplei GMP synthase requires careful attention to maintain structural integrity and enzymatic function:

Purification StepRecommended ApproachCritical Parameters
Cell lysisGentle mechanical disruptionBuffer: 50 mM Tris pH 8.0, 300 mM NaCl, 10% glycerol, 1 mM DTT, protease inhibitors
Initial captureAffinity chromatography (IMAC for His-tagged protein)Imidazole gradient (20-300 mM) to minimize non-specific binding
Intermediate purificationIon exchange chromatographySalt gradient based on theoretical pI of the enzyme
PolishingSize exclusion chromatographyBuffer containing stabilizing components; reveals oligomeric state
Quality controlActivity assay after each stepSpecific activity determination; fold purification calculation

Methodological protocol:

  • Harvest cells and resuspend in lysis buffer supplemented with 1% glutamine

  • Lyse cells using sonication or cell disruptor under controlled temperature (<10°C)

  • Clarify lysate by high-speed centrifugation (30,000×g, 30 min)

  • Apply supernatant to appropriate affinity resin

  • Elute protein and immediately apply protease to remove fusion tag if necessary

  • Analyze fractions by SDS-PAGE and activity assays

  • Pool active fractions and concentrate using appropriate molecular weight cutoff

  • Perform final polishing by size exclusion chromatography

How can metabolic labeling approaches be adapted to study T. whipplei GMP synthase function in cellular contexts?

Studying T. whipplei GMP synthase in cellular contexts presents unique challenges due to the bacterium's intracellular lifestyle and specialized metabolism:

Labeling ApproachApplicationMethodological Considerations
Radioactive glutamine tracingTrack glutamine incorporation into nucleotidesRequires axenic culture system with defined media
Isotope-labeled purinesExamine salvage pathway utilizationDifferentiate between de novo synthesis and salvage pathways
Fluorescent enzyme labelingVisualize enzyme localizationDesign cell-permeable probes specific to GMP synthase
Activity-based protein profilingIdentify active enzyme in complex samplesDevelop specific probes that covalently modify active site

Methodological approach:

  • Establish axenic T. whipplei culture using DMEM/F12 medium supplemented with 10% fetal calf serum, 1% L-glutamine, and 1% human non-essential amino acids

  • Introduce labeled metabolites (e.g., 13C-glutamine, 15N-labeled bases)

  • Extract metabolites at various time points

  • Analyze incorporation patterns using LC-MS/MS

  • Compare wild-type patterns with those in the presence of specific inhibitors

  • Correlate findings with recombinant enzyme kinetic data

How can potential contamination issues in recombinant protein preparation be identified and resolved?

Contamination can significantly impact experimental results, especially with enzymes requiring high purity for reliable activity measurements:

Contamination TypeDetection MethodResolution Strategy
Host protein impuritiesSDS-PAGE; Mass spectrometryAdditional purification steps; alternative tag positions
EndotoxinLAL assayEndotoxin removal columns; phase separation techniques
Nucleic acid contaminationA260/A280 ratio; DNA-specific dyesBenzonase treatment; additional ion exchange step
Proteolytic degradationWestern blot; N-terminal sequencingAdd protease inhibitors; optimize purification speed
Microbial contaminationGrowth on non-selective mediaWork aseptically; filter sterilize solutions

Methodological approach:

  • Implement rigorous quality control testing at each purification step

  • Verify protein identity by mass spectrometry

  • Assess enzymatic activity with specific substrates to confirm functionality

  • Evaluate protein homogeneity through analytical size exclusion chromatography

  • Perform thermal shift assays to assess protein stability and detect contaminants

  • Validate results by comparing multiple independent preparations

How can researchers distinguish between true enzymatic activity and artifacts in GMP synthase functional assays?

Distinguishing genuine enzymatic activity from artifacts requires careful experimental design and appropriate controls:

Potential ArtifactCauseControl Experiment
Background substrate degradationNon-enzymatic hydrolysisNo-enzyme control with identical incubation time
Activity from co-purifying contaminantsHost endogenous enzymesInactive mutant (e.g., active site mutation)
Buffer component interferenceReducing agents, metal ionsSystematically vary buffer components
Product inhibitionAccumulation of GMPTime-course measurements; coupled assay removing product
Aggregation effectsProtein concentration-dependent activityActivity measurements across protein concentration range

Methodological approach:

  • Include comprehensive controls in every experiment:

    • Complete reaction mix without enzyme

    • Complete reaction without individual substrates

    • Heat-inactivated enzyme

    • Known inhibitor of GMP synthase

  • Verify linear relationship between enzyme concentration and activity

  • Perform time-course assays to confirm linear initial rates

  • Validate results using multiple detection methods

  • Compare kinetic parameters with published values for related enzymes

  • Confirm substrate specificity through competition experiments

What are the main challenges in interpreting T. whipplei GMP synthase activity data in the context of thermal stress response?

Interpreting GMP synthase activity in relation to thermal stress requires consideration of multiple confounding factors:

ChallengeExperimental ComplexityAnalysis Approach
Differentiating direct temperature effects from adaptive responsesTemperature affects both enzyme structure and bacterial transcriptionCompare recombinant enzyme behaviors with whole-cell adaptation patterns
Multi-omics data integrationConnecting transcriptomic data with enzyme activityDevelop unified mathematical models incorporating multiple data types
Temporal dynamicsStress responses occur at different time scalesImplement time-course studies with consistent sampling intervals
Separating specific from global effectsMany proteins respond to thermal stressInclude control enzymes not expected to respond to thermal stress
In vitro versus in vivo correlationArtificial conditions may not reflect cellular environmentDesign cell-based assays that bridge the gap

Methodological approach:

  • Design experiments that parallel transcriptomic studies showing T. whipplei response to heat shock (43°C) and cold shock (4°C)

  • Measure enzyme kinetic parameters (Km, kcat) across temperature range

  • Determine temperature optima and compare with growth temperature

  • Assess thermal stability using differential scanning fluorimetry

  • Identify potential post-translational modifications affecting temperature response

  • Integrate findings with global transcriptome data to identify coordinated responses

How might T. whipplei GMP synthase be exploited as a therapeutic target?

T. whipplei's limited metabolism and dependence on host-derived nutrients makes GMP synthase a potential therapeutic target:

Targeting StrategyScientific RationaleResearch Approach
Structure-based inhibitor designGMP synthase has distinct structural features compared to human enzymeSolve crystal structure; identify unique binding pockets
Metabolic vulnerabilityGlutamine dependency for nucleotide synthesis Design competitive inhibitors of glutamine binding site
Bacterial specificityTarget differences between bacterial and human enzymesComparative analysis of active sites across species
Delivery to intracellular bacteriaT. whipplei resides within macrophagesDevelop macrophage-targeting drug delivery systems
Combination therapyTarget multiple aspects of nucleotide metabolismTest synergy between GMP synthase inhibitors and other antimicrobials

Methodological approach:

  • Determine high-resolution structure of T. whipplei GMP synthase

  • Perform virtual screening of compound libraries against identified binding sites

  • Synthesize and test promising candidates in enzyme assays

  • Evaluate specific inhibitors in axenic T. whipplei cultures

  • Assess activity in cellular infection models

  • Investigate pharmacokinetics and toxicity profiles of lead compounds

How can genomic and proteomic approaches enhance our understanding of T. whipplei GMP synthase regulation?

Integrative -omics approaches can provide deeper insights into GMP synthase regulation:

ApproachApplicationMethodological Implementation
Comparative genomicsIdentify regulatory elements controlling guaA expressionAnalyze promoter regions across T. whipplei strains and related species
TranscriptomicsDetermine expression patterns under various conditionsRNA-seq analysis of T. whipplei under different stresses and growth conditions
ProteomicsIdentify post-translational modificationsMS/MS analysis of GMP synthase purified from T. whipplei
MetabolomicsMap metabolic fluxes through purine synthesis pathwaysIsotope tracing studies in axenic culture
InteractomicsIdentify protein interaction partnersPull-down assays; bacterial two-hybrid screens

Methodological approach:

  • Perform RNA-seq analysis of T. whipplei under conditions relevant to infection

  • Use ChIP-seq to identify regulators binding near the guaA gene

  • Apply ribosome profiling to assess translation efficiency

  • Implement proteomics to identify post-translational modifications

  • Construct interaction networks focused on nucleotide metabolism enzymes

  • Integrate data using systems biology approaches to model GMP synthase regulation in the context of T. whipplei's reduced genome

What insights might recombinant T. whipplei GMP synthase provide about evolution of parasitic bacteria with reduced genomes?

T. whipplei's status as the only known reduced genome species (<1 Mb) within Actinobacteria makes its GMP synthase valuable for evolutionary studies:

Evolutionary QuestionResearch SignificanceInvestigative Approach
Selective pressure on essential enzymesUnderstanding molecular adaptation during genome reductionComparative sequence analysis across bacterial phyla
Functional constraints in reduced genomesIdentifying minimal requirements for enzyme functionStructure-function relationship studies
Host adaptation signaturesDetecting features specialized for human host environmentAnalysis of substrate specificity shifts
Evolutionary rate in parasitesTesting molecular clock hypothesesPhylogenetic analysis of guaA across multiple bacterial lineages
Gene retention principlesUnderstanding why specific metabolic genes are retainedMetabolic network analysis in genome-reduced species

Methodological approach:

  • Conduct comprehensive sequence analysis of GMP synthase across bacterial species with different genome sizes

  • Reconstruct ancestral sequences to trace evolutionary trajectory

  • Identify sites under positive selection using dN/dS analysis

  • Compare enzyme kinetics of recombinant GMP synthases from related bacteria with different genome sizes

  • Correlate functional changes with genomic reduction events

  • Develop models predicting evolutionary trajectories of essential enzymes during genome reduction

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.